Histamine dihydrochloride: inhibiting oxidants and synergising IL-2-mediated immune activation in the tumour microenvironment.
about
Novel roles of reactive oxygen species in the pathogenesis of acute myeloid leukemia.A prospective, double-blind phase II study evaluating the safety and efficacy of a topical histamine gel for the prophylaxis of oral mucositis in patients post hematopoietic stem cell transplantation.Boron neutron capture therapy (BNCT) translational studies in the hamster cheek pouch model of oral cancer at the new "B2" configuration of the RA-6 nuclear reactor.Histamine reduces boron neutron capture therapy-induced mucositis in an oral precancer model.Antihistamine use and immunoglobulin E levels in glioma risk and prognosis.
P2860
Histamine dihydrochloride: inhibiting oxidants and synergising IL-2-mediated immune activation in the tumour microenvironment.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Histamine dihydrochloride: inh ...... n the tumour microenvironment.
@ast
Histamine dihydrochloride: inh ...... n the tumour microenvironment.
@en
Histamine dihydrochloride: inh ...... n the tumour microenvironment.
@nl
type
label
Histamine dihydrochloride: inh ...... n the tumour microenvironment.
@ast
Histamine dihydrochloride: inh ...... n the tumour microenvironment.
@en
Histamine dihydrochloride: inh ...... n the tumour microenvironment.
@nl
prefLabel
Histamine dihydrochloride: inh ...... n the tumour microenvironment.
@ast
Histamine dihydrochloride: inh ...... n the tumour microenvironment.
@en
Histamine dihydrochloride: inh ...... n the tumour microenvironment.
@nl
P2860
P356
P1476
Histamine dihydrochloride: inh ...... n the tumour microenvironment.
@en
P2093
Agarwala SS
Sabbagh MH
P2860
P304
P356
10.1517/14712598.1.5.869
P407
P577
2001-09-01T00:00:00Z